Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
Yang
Otto O
OO
Division of Infectious Diseases, Department of Medicine and Department of Microbiology, Immunology, and Molecular Genetics, UCLA AIDS Institute, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. oyang@mednet.ucla.edu
D016915:AIDS Vaccines / Q000276:immunology*; D015195:Drug Design; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D015497:HIV-1 / Q000276:immunology* / Q000472:pathogenicity; D054298:Human Immunodeficiency Virus Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D006801:Humans; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D016915:AIDS Vaccines; D054298:Human Immunodeficiency Virus Proteins